Navigation Links
First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
Date:4/25/2012

of leg or arm discomfort from moving around
  • Item 4: severity of sleep disturbance due to RLS symptoms
  • Item 5: tiredness or sleepiness during the day due to RLS symptoms
  • Item 6: severity of RLS as a whole
  • Item 7: frequency of RLS symptoms
  • Item 8: average severity when RLS symptoms occurred
  • Item 9: impact on ability to carry out daily affairs
  • Item 10: severity of mood disturbance due to RLS symptoms
  • In these post-hoc analyses, the severity and impact of RLS symptoms were analysed using mean change from baseline to end of maintenance in individual IRLS item scores. Results presented below should be viewed in the context of the post-hoc analyses. In addition the p-values reported are exploratory and additional prospective studies are needed to further our understanding in this area.

    Post-hoc analysis of the European study (SP790)

    In the post-hoc analysis of the European study improvements were observed with rotigotine versus placebo in 9 of 10 individual IRLS items as listed below:

    Core RLS symptoms

    • Discomfort in legs or arms (treatment difference [LS mean (95% confidence interval)]:  -0.8 [-1.1, -0.6]); p<0.0001
    • Need to move around: (-0.8 [-1.1,-0.5]); p<0.0001
    • Severity of RLS as a whole: (-0.8 [-1.1, -0.6]); p<0.0001
    • Average severity when symptoms occurred: (-0.7 [-1.0, -0.5]); p<0.0001
    • Frequency of symptoms: (-1.0 [-1.3, -0.6]); p<0.0001

    Improvements in relief of 'RLS discomfort by movement' were numerically greater with rotigotine transdermal system versus placebo but did not reach significance (-0.1 [-0.3, 0.0], p=0.1216.

    Impact of RLS symptoms

    • Severity of sleep disturbance: (-0.9 [-1.1, -0.6]); p<0.0
      '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
    2. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
    3. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
    4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    5. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
    6. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
    7. Insmed to Host 2012 First Quarter Earnings Conference Call
    8. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
    9. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
    10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
    11. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... de mayo de 2015 Dipexium ... compañía farmacéutica de fase tardía centrada en ... cream 0.8%), y colaboradores de investigación clínica, ... destacando el diseño innovador de los ensayos ... que evalúan Locilex®, su nuevo péptido de ...
    (Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
    (Date:5/22/2015)... 22, 2015 The Assistance Fund announces the ... provides financial assistance for copay to individuals diagnosed with ... the addition of the Melanoma Copay Assistance Program to ... , executive director. "With each additional program we are ... world where no one is denied access to medications ...
    Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2
    ... Life Length, the world,s leading telomere testing and services ... have joined its Scientific Advisory Board ("SAB"). ... delighted to welcome these world-renowned telomere and telomerase experts ... global leadership.  Dr Chang is especially well known for ...
    ... Colo., March 6, 2012   Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products , today ... of best practices research, tools and metrics for patent ... again ranked Heska,s Science Strength in the top 50 ...
    Cached Medicine Technology:Drs Sandy Chang and Kathleen Collins Join LIFE LENGTH®'s Scientific Advisory Board 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 3
    (Date:5/24/2015)... New York (PRWEB) May 24, 2015 ... treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its ... progress of the multidistrict litigation. According to court ... District of Illinois, the Conference will be convened ... re: Testosterone Replacement Therapy Product Liability Litigation - ...
    (Date:5/24/2015)... 2015 Indiana Fiber Network, LLC (IFN), ... Telecom of America, Inc. (MTA) has selected IFN as ... Childs, IFN Enterprise Sales Manager, fiber route diversity and ... fiber transport provides MTA with the diverse fiber transport ... 1 Internet and voice carriers located at Henry Street ...
    (Date:5/24/2015)... Lake Geneva, WI (PRWEB) May 24, ... Bea Mercy Health System CEO ... their principal and honored at the ... event held April 15 at Geneva ... include (by school): ,     -Badger High ...
    (Date:5/23/2015)... FL (PRWEB) May 23, 2015 On Saturday, ... build a new playground for Branches Florida City exactly five ... former play space in 2010. , A large fire tore ... playground on May 23, 2010 in the middle of the ... The fire was later declared arson even though it is ...
    (Date:5/23/2015)... Dr. David Benvenuti, an experienced plastic surgeon who practices ... article to his website that takes an in-depth look ... in the fascinating blog, he has recently had several young ... as “gauging,” the technique involves placing larger and larger gauge ... eventually stretch the holes out to incredible sizes. As the ...
    Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2
    ... are uncommon as children enter adolescence, parasomnias present in ... a research abstract that will be presented Monday, June ... the 24th annual meeting of the Associated Professional Sleep ... persistence after five years was 29 percent for children ...
    ... Newly reported results from a major clinical trial ... chemotherapy for women with advanced ovarian cancer and ... afterwards significantly extends progression-free survival. Women receiving the ... disease for 14.1 months, compared to 10.3 months ...
    ... found compound slowed drug-resistant medulloblastoma in children , ... has found that a targeted treatment for medulloblastoma -- ... may one day be able to treat drug-resistant forms ... patients currently survive medulloblastoma," said Dr. Amar Gajjar, lead ...
    ... survival, researchers report , SATURDAY, June 5 (HealthDay News) -- ... first in its class, improved survival by 68 percent in ... parts of the body. , This is big news in ... to budge, despite numerous efforts to come up with an ...
    ... CHICAGO - Selenium, a supplement taken daily by millions in ... diseases, has proven to be of no benefit in reducing ... recurrence or second primary malignancy, according to results of an ... study, initiated by the Eastern Cooperative Oncology Group, were presented ...
    ... ... Day 2010 GreatDad Recommends Award and Mr. Dad Seal of Approval Recipients , ... San Francisco, Calif. (PRWEB) June 5, 2010 ... for a real treat. Presented by Mr. Dad and GreatDad.com, the results of the Fathers ...
    Cached Medicine News:Health News:Childhood parasomnias such as sleepwalking and bedwetting may persist into adolescence 2Health News:New treatment regimen shown effective against advanced ovarian cancer 2Health News:Targeted Therapy Shows Promise Against Deadly Brain Cancer 2Health News:Novel Drug Combats Advanced Melanoma 2Health News:Novel Drug Combats Advanced Melanoma 3Health News:Selenium shows no benefit in prevention of lung cancer 2Health News:Selenium shows no benefit in prevention of lung cancer 3Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's &#8216;Seal of Approval' Picks 2Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's &#8216;Seal of Approval' Picks 3Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's &#8216;Seal of Approval' Picks 4
    The AP250 Auto Projector is a remote-controlled, programmable, random-access, high-resolution, ophthalmic projector....
    The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
    The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
    ... The BiPAP Pro with Bi-Flex bi-level system, ... that the BiPAP Pro takes to change ... Digital Auto-Trak Sensitivity™ which automatically triggers the ... pressures based on the patients breathing rhythm. ...
    Medicine Products: